Risk stratification and treatment benefits in patients with non-ST-elevation acute coronary syndromes.
White
H D
HD
Wong
C K
CK
D000208:Acute Disease; D015415:Biomarkers / Q000097:blood; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D003402:Creatine Kinase / Q000097:blood / Q000187:drug effects; D052279:Creatine Kinase, MB Form; D004562:Electrocardiography; D006801:Humans; D007527:Isoenzymes / Q000097:blood / Q000187:drug effects; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000627:therapeutic use; D018570:Risk Assessment; D013577:Syndrome; D016896:Treatment Outcome; D014336:Troponin / Q000097:blood / Q000187:drug effects; D016277:Ventricular Function, Left / Q000502:physiology
D015415:Biomarkers; D007527:Isoenzymes; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D014336:Troponin; D003402:Creatine Kinase; D052279:Creatine Kinase, MB Form